-DOCSTART- -X- O
In -X- _ O
chronic -X- _ B-Patient
HCV -X- _ I-Patient
infection -X- _ I-Patient
, -X- _ O
treatment -X- _ O
failure -X- _ O
and -X- _ O
defective -X- _ O
host -X- _ O
immune -X- _ O
response -X- _ O
highly -X- _ O
demand -X- _ O
improved -X- _ O
therapy -X- _ O
strategies. -X- _ O
Vγ9Vδ2 -X- _ O
T-cells -X- _ O
may -X- _ O
inhibit -X- _ O
HCV -X- _ O
replication -X- _ O
in -X- _ O
vitro -X- _ O
through -X- _ O
IFN-γ -X- _ O
release -X- _ O
after -X- _ O
Phosphoantigen -X- _ O
( -X- _ O
PhAg -X- _ O
) -X- _ O
stimulation. -X- _ O
The -X- _ O
aim -X- _ O
of -X- _ O
our -X- _ O
work -X- _ O
was -X- _ O
to -X- _ O
analyze -X- _ O
Vγ9Vδ2 -X- _ O
T- -X- _ O
cell -X- _ O
functionality -X- _ O
during -X- _ O
chronic -X- _ B-Patient
HCV -X- _ I-Patient
infection -X- _ I-Patient
, -X- _ O
studying -X- _ O
the -X- _ O
role -X- _ O
of -X- _ O
IFN-α -X- _ B-Intervention
on -X- _ O
their -X- _ O
function -X- _ O
capability. -X- _ O
IFN-γ -X- _ O
production -X- _ O
by -X- _ O
Vγ9Vδ2 -X- _ O
T-cells -X- _ O
was -X- _ O
analyzed -X- _ O
in -X- _ O
vitro -X- _ O
in -X- _ O
24 -X- _ B-Patient
HCV-infected -X- _ I-Patient
patients -X- _ I-Patient
and -X- _ O
35 -X- _ B-Comparison
healthy -X- _ I-Comparison
donors -X- _ I-Comparison
( -X- _ I-Comparison
HD -X- _ I-Comparison
) -X- _ I-Comparison
after -X- _ O
PhAg -X- _ O
stimulation -X- _ O
with -X- _ O
or -X- _ O
without -X- _ O
IFN-α. -X- _ O
The -X- _ O
effect -X- _ O
of -X- _ O
in -X- _ O
vivo -X- _ O
PhAg -X- _ O
/ -X- _ O
IFN-α -X- _ O
administration -X- _ O
on -X- _ O
plasma -X- _ O
IFN-γ -X- _ O
levels -X- _ O
was -X- _ O
analyzed -X- _ O
in -X- _ O
M. -X- _ O
fascicularis -X- _ O
monkeys. -X- _ O
A -X- _ O
quantitative -X- _ O
analysis -X- _ O
of -X- _ O
IFN-γ -X- _ O
mRNA -X- _ O
level -X- _ O
and -X- _ O
stability -X- _ O
in -X- _ O
Vγ9Vδ2 -X- _ O
T-cells -X- _ O
was -X- _ O
also -X- _ O
evaluated. -X- _ O
During -X- _ O
chronic -X- _ B-Patient
HCV -X- _ I-Patient
infection -X- _ I-Patient
, -X- _ O
Vγ9Vδ2 -X- _ B-Outcome
T-cells -X- _ I-Outcome
showed -X- _ I-Outcome
an -X- _ I-Outcome
effector -X- _ I-Outcome
/ -X- _ I-Outcome
activated -X- _ I-Outcome
phenotype -X- _ I-Outcome
and -X- _ I-Outcome
were -X- _ I-Outcome
significantly -X- _ I-Outcome
impaired -X- _ I-Outcome
in -X- _ I-Outcome
IFN-γ -X- _ I-Outcome
production. -X- _ I-Outcome
Interestingly -X- _ I-Outcome
, -X- _ I-Outcome
IFN-α -X- _ I-Outcome
was -X- _ I-Outcome
able -X- _ I-Outcome
to -X- _ I-Outcome
improve -X- _ I-Outcome
their -X- _ I-Outcome
IFN-γ -X- _ I-Outcome
response -X- _ I-Outcome
to -X- _ I-Outcome
PhAg -X- _ I-Outcome
both -X- _ I-Outcome
in -X- _ I-Outcome
vitro -X- _ I-Outcome
in -X- _ I-Outcome
HD -X- _ I-Outcome
and -X- _ I-Outcome
HCV-infected -X- _ I-Outcome
patients -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
in -X- _ I-Outcome
vivo -X- _ I-Outcome
in -X- _ I-Outcome
Macaca -X- _ I-Outcome
fascicularis -X- _ I-Outcome
primates. -X- _ I-Outcome
Finally -X- _ I-Outcome
, -X- _ I-Outcome
IFN-α -X- _ I-Outcome
increased -X- _ I-Outcome
IFN-γ-mRNA -X- _ I-Outcome
transcription -X- _ I-Outcome
and -X- _ I-Outcome
stability -X- _ I-Outcome
in -X- _ I-Outcome
PhAg- -X- _ I-Outcome
activated -X- _ I-Outcome
Vγ9Vδ2 -X- _ I-Outcome
T-cells. -X- _ I-Outcome
Altogether -X- _ O
our -X- _ O
results -X- _ O
show -X- _ O
a -X- _ O
functional -X- _ B-Outcome
impairment -X- _ I-Outcome
of -X- _ I-Outcome
Vγ9Vδ2 -X- _ I-Outcome
T-cells -X- _ I-Outcome
during -X- _ I-Outcome
chronic -X- _ I-Outcome
HCV -X- _ I-Outcome
infection -X- _ I-Outcome
that -X- _ I-Outcome
can -X- _ I-Outcome
be -X- _ I-Outcome
partially -X- _ I-Outcome
restored -X- _ I-Outcome
by -X- _ I-Outcome
using -X- _ I-Outcome
IFN-α. -X- _ I-Outcome
A -X- _ O
study -X- _ O
aimed -X- _ O
to -X- _ O
evaluate -X- _ O
the -X- _ O
antiviral -X- _ O
impact -X- _ O
of -X- _ O
PhAg -X- _ O
/ -X- _ O
IFN-α -X- _ O
combination -X- _ O
may -X- _ O
provide -X- _ O
new -X- _ O
insight -X- _ O
in -X- _ O
designing -X- _ O
possible -X- _ O
combined -X- _ O
strategies -X- _ O
to -X- _ O
improve -X- _ O
HCV -X- _ O
infection -X- _ O
treatment -X- _ O
outcome -X- _ O
. -X- _ O

